Population (July 2006 estimate)
28.3m
GDP (2005 - PPP basis)
$169.5bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Health expenditure as proportion of GDP (predicted 2007)
Size of pharmaceutical market (2004)
Percentage of GDP spent on pharmaceuticals (2002)
Pharmaceutical market growth rate
Local currency
Nuevo Sol (PEN)
Summary: Peru
The unpopularity of the current government has hampered its efforts to reform healthcare. There have been complaints that the Ministry of Health’s system to regulate the introduction of new products and their pricing is inadequate. The situation is further complicated by ongoing investigations into the rampant corruption of the previous administration.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
There are no news items for this country.
View all articles for Latin America »
Related Items